Composition : Paclitaxel IP 6mg + Polyoxyl 35 Castor oil IP 527mg + Dehydrtes Alcohol IP 49.7% v/v
Dosage Form : Injection
Packaging Type : Vial
Packaging : 30gm
Price : ₹0/-
Please Contact For Best Price
Packlin 30 Injection is a critical intravenous chemotherapy solution containing Paclitaxel 30 mg, an essential drug in the Taxane class. This smallest presentation is highly valued in clinical settings for achieving precise, low-dose administration protocols (e.g., weekly regimens, pediatric oncology) and for significantly minimizing the costly drug wastage often associated with larger vials.
Mechanism and Impact:Paclitaxel is a cytotoxic agent that acts by stabilizing microtubules, preventing their breakdown and essential restructuring required for cell division. This forces the rapidly dividing cancer cells (Breast, Ovarian, Lung, etc.) into mitotic arrest, leading to programmed cell death.
Key Therapeutic Uses:
-
Breast Cancer: Used in adjuvant, neoadjuvant, and metastatic settings.
-
Ovarian Cancer: Standard treatment for advanced ovarian carcinoma.
-
Non-Small Cell Lung Cancer (NSCLC): Used in combination regimens.
-
Cost-Efficiency: The 30 mg vial is a preferred option for doses that would otherwise require discarding significant amounts of drug from larger vials.
We offer an exclusive PCD Pharma Franchise opportunity for Packlin 30 Injection, enabling partners to meet the strong institutional demand for flexible, low-wastage oncology injectables.
Read More